Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11

Cancer Genetics and Cytogenetics

Volumn 160, Issue 1, 2005, Pages 68-72

  Sierra, Magdalena ^a   Hernández, Jesús M ^a   García, Juan L ^a   Gutiérrez, Norma C ^a   Pérez, José J ^a   Vidriales, M Belén ^a   Ramos, Fernando ^b   Hernández, José M ^c   Romero, Mercedes ^d   González, M Belén ^a   Galende, Josefina ^e   San Miguel, Jesús F ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b Complejo Asistencial Universitario de León   (Spain)

^c HOSPITAL GENERAL DE SEGOVIA   (Spain)

^d HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^e HOSPITAL EL BIERZO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOGENETICS; DYSPLASIA; FEMALE; GENE EXPRESSION; HEMATOLOGY; HUMAN; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INCIDENCE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRISOMY; TRISOMY 11;

AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; TRISOMY;

EID: 20444374479     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.11.008     Document Type: Article

References (14)

1. J.W. Vardiman, N.L. Harris, and R.D. Brunning The World Health Organization (WHO) classification of the myeloid neoplasms Blood 100 2002 2292 2302
2. K. Heinonen, K. Mrozek, D. Lawrence, D.C. Arthur, M.J. Pettenati, J. Stamberg, M.B. Qumsiyeh, R.S. Verma, J. MacCallum, C.A. Schiffer, and C.D. Bloomfield Clinical characteristics of patients with de novo acute myeloid leukaemia and isolated trisomy 11: a Cancer and Leukemia Group B study Br J Haematol 101 1998 513 520
3. Y.L. Kwong, and K.F. Wong Acute myeloid leukemia with trisomy 11: a molecular cytogenetic study Cancer Genet Cytogenet 99 1997 19 23
4. M.L. Slovak, S.T. Traweek, C.L. Willman, D.R. Head, K.J. Kopecky, R.E. Magenis, F.R. Appelbaum, and S.J. Forman Trisomy 11: an association with stem/progenitor cell immunophenotype Br J Haematol 90 1995 266 273
5. C. Bilhou-Nabera, J.F. Lesesve, G. Marit, M. Lafage, N. Dastugue, B. Goullin, C. Arnoulet, A.M. Stoppa, F. Huguet, and M. Attal Trisomy 11 in acute myeloid leukemia: ten cases [Letter] Leukemia 8 1994 2240 2241
6. J. Meletis, M. Samarkos, D. Abazis, E. Michali, S. Vavourakis, E. Plata, J. Rombos, K. Konstantopoulos, K. Pangalos, X. Yataganas, and D. Loukopoulos Trisomy 11 with loss of the Y chromosome and trisomy 13 in a case of de novo acute myeloid leukemia Cancer Genet Cytogenet 86 1996 65 68
7. L. Trakhtenbrot, E. Rosner, N. Gipsh, S. Berman, O. Sofer, F. Brok-Simoni, G. Rechavi, and I. Ben-Bassat Hexasomy of chromosome 8 and trisomy of chromosome 11 characterize two karyotypically independent clones in a case of acute non-lymphocytic leukemia: conventional cytogenetic and FISH investigation Cancer Genet Cytogenet 85 1995 1 4
8. E.S. Jaffe N.L. Harris H. Stein J.W. Vardiman Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours 2001 IARC Press Lyon
9. J.M. Bennett, D. Catovsky, M.T. Daniel, G. Flandrin, D.A. Galton, H.R. Gralnick, and C. Sultan Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group Br J Haematol 33 1976 451 458
10. J.M. Hernandez, M.B. Gonzalez, I. Granada, N. Gutierrez, C. Chillon, F. Ramos, J.M. Ribera, M. Gonzalez, E. Feliu, and J. San Miguel Detection of inv(16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo Haematologica 85 2000 481 485
11. ISCN 1995: an international system for human cytogenetic nomenclature (1995) F. Mitelman 1995 S. Karger Basel
12. M.L. Slovak, K.J. Kopecky, P.A. Cassileth, D.H. Harrington, K.S. Theil, A. Mohamed, E. Paietta, C.L. Willman, D.R. Head, J.M. Rowe, S.J. Forman, and F.R. Appelbaum Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study Blood 96 2000 4075 4083
13. D. Grimwade, H. Walker, G. Harrison, F. Oliver, S. Chatters, C. Harrison, K. Wheatley, A. Burnett, and A. Goldstone The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): Analysis of 1065 patients entered into the United Kingdom Medical Research Council AML 11 trial Blood 98 2001 1312 1320
14. M.A. Caligiuri, M.P. Strout, S.A. Schichman, K. Mrozek, D.C. Arthur, G.P. Herzig, M.R. Baer, C.A. Schiffer, K. Heinonen, S. Knuutila, T. Nousiainen, T. Ruutu, A.W. Block, P. Schulman, J. Pedersen-Bjergaard, C.M. Croce, and C.D. Bloomfield Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11 Cancer Res 56 1996 1418 1425